Outcomes in Treatment of Infantile Spasms With Pulse Methylprednisolone

Journal of Child Neurology - Tập 25 Số 8 - Trang 948-953 - 2010
John R. Mytinger1, Mark Quigg2, William C. Taft2, Marcia L. Buck3, Robert S. Rust1
1Department of Neurology, University of Virginia Health System, Charlottesville, Virginia, Department of Pediatrics, University of Virginia Health System, Charlottesville, Virginia
2Department of Neurology, University of Virginia Health System, Charlottesville, Virginia
3Department of Pediatrics, University of Virginia Health System, Charlottesville, Virginia

Tóm tắt

The authors report their experience with intravenous methylprednisolone for the treatment of infantile spasms. A pulse dose of 20 mg/kg intravenous methylprednisolone on each of 3 successive days, followed by a 2-month oral prednisolone taper, led to the rapid remission (range, 2-6 days) of infantile spasms in 5 of 10 (50%) infants. In the subgroup of infants treated within 1 month of onset, 5 of 6 (83%) experienced remission within 6 days. The authors estimate the medication cost of intravenous methylprednisolone with prednisolone taper to be less than $200. In comparison, the cost of a typical course of adrenocorticotropic hormone in the United States can exceed $70 000. Initial treatment with intravenous methylprednisolone and/or oral corticosteroids is a reasonable cost-effective approach to infantile spasms. The lack of serious side effects, low cost, availability, ease of administration, and comparable efficacy suggests that intravenous methylprednisolone merits consideration for study in randomized prospective trials.

Từ khóa


Tài liệu tham khảo

10.1002/ana.410060306

10.1111/j.1528-1157.1984.tb04195.x

Gibbs FA, 1952, Atlas of Electroencephalography

10.1016/S0387-7604(01)00307-2

10.1016/S0022-3476(88)80318-4

10.1111/j.1528-1157.1983.tb04874.x

10.1212/WNL.43.11.2322

10.1016/S0022-3476(80)80706-2

10.1016/S0022-3476(83)80606-4

10.1212/WNL.33.8.966

10.1212/WNL.39.8.1027

10.1016/S0022-3476(05)81379-4

10.1016/S1474-4422(05)70199-X

10.1111/j.0013-9580.2004.30503.x

10.1177/088307389400900420

10.1111/j.1469-8749.1996.tb15091.x

10.1177/0883073807302606

10.1212/01.WNL.0000127773.72699.C8

Baram TZ, 1996, Pediatrics, 97, 375, 10.1542/peds.97.3.375

10.1111/j.1469-8749.1998.tb15402.x

Hancock EC, 2008, Cochrane Database Syst Rev, 4, CD001770

10.1016/S0140-6736(04)17400-X

Anon., 2007, Questcor board approves new strategy and business model for H.P. Acthar Gel. Questcor News Release

10.1016/S0022-3476(81)80249-1

10.1136/adc.2007.126144

10.1111/j.1528-1157.1979.tb04820.x

Hrachovy RA, 2003, InfantileSpasms. Diagnosis,Management and Prognosis

Thông tin
Thông tin xuất bản

Journal of Child Neurology

Tập 25 Số 8

948-953

Thông tin tác giả